The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,2,3-thiadiazole-30-methy 3beta-hydroxy-11-oxo-18betaH-Olean-12-en-30-oic acid ID: ALA4864423
PubChem CID: 164620028
Max Phase: Preclinical
Molecular Formula: C31H44N2O3S
Molecular Weight: 524.77
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)[C@@]1(C)CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)Cc6snnc6C(C)(C)C5CC[C@]43C)[C@@H]2C1
Standard InChI: InChI=1S/C31H44N2O3S/c1-26(2)22-9-10-31(7)23(29(22,5)17-21-24(26)32-33-37-21)20(34)15-18-19-16-28(4,25(35)36-8)12-11-27(19,3)13-14-30(18,31)6/h15,19,22-23H,9-14,16-17H2,1-8H3/t19-,22?,23?,27+,28-,29-,30+,31+/m0/s1
Standard InChI Key: NYUZZDPQWQCYAE-LDDYBPTGSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
18.2460 -22.8772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2460 -21.2428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9513 -21.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9523 -22.4728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6566 -22.8782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3644 -22.4710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6546 -21.2438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3653 -21.6544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3641 -20.0156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6508 -20.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0748 -20.4262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0738 -21.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7801 -21.6561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4921 -21.2489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7822 -20.0145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4926 -20.4327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2060 -20.0289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2153 -19.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5049 -18.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7853 -19.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0795 -18.2011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9197 -18.2011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8602 -17.4138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6604 -23.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8202 -23.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9440 -20.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3596 -20.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0695 -22.0642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9427 -20.0175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.1950 -20.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0695 -19.6043 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
23.8708 -18.4048 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4430 -17.8213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5407 -22.4728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5362 -21.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7577 -21.4074 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.2810 -22.0711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7650 -22.7295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35 2 1 0
34 1 1 0
1 4 1 0
3 2 1 0
3 4 1 0
3 7 1 0
4 5 1 0
5 6 1 0
6 8 1 0
7 8 1 0
7 10 1 0
8 12 1 0
11 9 2 0
9 10 1 0
11 12 1 0
11 15 1 0
12 13 1 0
13 14 1 0
14 16 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 1 1
19 22 1 0
21 23 2 0
1 24 1 0
1 25 1 0
3 26 1 1
8 27 1 1
12 28 1 6
10 29 2 0
16 30 1 1
15 31 1 1
21 32 1 0
32 33 1 0
34 35 2 0
35 36 1 0
36 37 1 0
37 38 2 0
38 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 524.77Molecular Weight (Monoisotopic): 524.3073AlogP: 6.71#Rotatable Bonds: 1Polar Surface Area: 69.15Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 7.27CX LogD: 7.27Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.38Np Likeness Score: 2.14
References 1. Baltina LA, Lai HC, Liu YC, Huang SH, Hour MJ, Baltina LA, Nugumanov TR, Borisevich SS, Khalilov LM, Petrova SF, Khursan SL, Lin CW.. (2021) Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro., 41 [PMID:34022526 ] [10.1016/j.bmc.2021.116204 ]